• Home
  • New Patient Info
  • Patient Stories
  • News
  • Contact Us
Make A Donation

A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis

May 8, 2017

Journal of Neurology, 2013: THC fares well vs. Placebo in treatment of pain.    

See full article – A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis

There has never been a more important time to support this vital work. We are fighting for the rights of all Utahns: for dignity, for respect, and to improve our quality of life.

DONATE NOW

 

  • Facebook
  • Twitter
Designed by CMD | © 2015-2022 TRUCE UTAH